水蛭肽研究应用进展
李珊,盖鲁粤
摘要(Abstract)：
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 李珊,盖鲁粤
参考文献(References)：
- [1]Markwardt F.Hirudin;aninhibitor of blood coagulationfrommedical leeches.Blut,1958,4:160-161.
- [2]Dodt J,Schmitz T,Schafer T,et al.Expression,secretion and pro-cessing of hirudinin E.coli usingthe alkaline phosphatase signal se-quence.FEBS Lett,1986,202:373-377.
- [3]Maraganore JM,Adelman BA.Hirulog:a direct thrombin inhibitor for management of acute coronary syndromes.Coron Artery Dis,1996,7:438-448.
- [4]Hamelink JK,Tang DB,Barr CF,et al.Inhibition of platelet depo-sition by combined hirulog and aspirinin a rat carotid endarterectomy model.J Vase Sury,1995,21:492-498.
- [5]Yenari MA,de Crespigny A,Palmet JT,et al.Improved perfusion withrt-PAand hirulogin a rabbit model of embolic stroke.J Cereb Blood Flow Metab,1997,17:401-411.
- [6]Yao SK,Ober JC,Ferguson JJ,et al.Combination of inhibition of thrombin and blokade of thromboxane A2synthetase andreceptors en-hances thrombolysis and delays reoccusion in canine coronary arter-ies.Circulation,1992,86:1993-1999.
- [7]SarembockIJ,Gertz SD,Thome LM,et al.Effectiveness of hirulog inreducingrestenosis after balloonangioplastyof atheroscleroticfemo-ral arteries in rabbits.J Vasc Res,1996,33:308-314.
- [8]Muller DW,Gordon D,Topol EJ,et al.Sustained-release local hir-ulog therapy decrease early thrombosis but not neointimal thickening after arterial stenting.Am Heart J,1996,131:211-218.
- [9]Fuchs J,Cannon CP.Hirulog in the treatment of unstable angina.Results of the Thrombin Inhibition in Myocardial Ischemia(TIMI7)trial.Circulation,1995,92:727-733.
- [10]Theroux P,Perez-Villa F,Waters D,et al.Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapyto streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.Circulation,1995,91:2132-2139.
- [11]Carswell CI,Plosker GL.Bivalirudin:a reviewof its potential place inthe management of acute coronary syndromes.Drugs,2002,62:841-870.
- [12]Gurm HS,Sarembock IJ,Kereiakes DJ,et al.Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus:an analysis fromthe randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events(REPLACE)-2trial.J AmColl Cardiol,2005,45:1932-1938.
- [13]GinsberyJS,Nurmohamed MT,Gent M,et al.Use of Hiruloginthe prevention of venous thrombosis after major hip or knee surgery.Cir-culation,1994,90:2385-2389.
- [14]Chamberlin JR,Lewis B,Leya F,et al.Successful treatment of he-parin-associatedthrombocytopenia and thrombosis using hirulog.Can J Cardiol,1995,11:511-514.